Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy.

MLA

Fujita, Hayato, et al. “Gene Expression Levels as Predictive Markers of Outcome in Pancreatic Cancer after Gemcitabine-Based Adjuvant Chemotherapy.” Neoplasia (New York, N.Y.), vol. 12, no. 10, Oct. 2010, pp. 807–17. EBSCOhost, https://doi.org/10.1593/neo.10458.

APA

Fujita, H., Ohuchida, K., Mizumoto, K., Itaba, S., Ito, T., Nakata, K., Yu, J., Kayashima, T., Souzaki, R., Tajiri, T., Manabe, T., Ohtsuka, T., & Tanaka, M. (2010). Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy. Neoplasia (New York, N.Y.), 12(10), 807–817. https://doi.org/10.1593/neo.10458

Chicago

Fujita, Hayato, Kenoki Ohuchida, Kazuhiro Mizumoto, Soichi Itaba, Tetsuhide Ito, Kohei Nakata, Jun Yu, et al. 2010. “Gene Expression Levels as Predictive Markers of Outcome in Pancreatic Cancer after Gemcitabine-Based Adjuvant Chemotherapy.” Neoplasia (New York, N.Y.) 12 (10): 807–17. doi:10.1593/neo.10458.